CNSI-Fe(II) / Sichuan Enray Pharma - LARVOL DELTA

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor (clinicaltrials.gov) - P1 | N=19 | Completed | Sponsor: Sichuan Enray Pharmaceutical Sciences Company | Trial completion date: Feb 2024 ➔ Feb 2025 | Recruiting ➔ Completed | Trial primary completion date: Dec 2023 ➔ Sep 2024

Trial completion • Trial completion date • Trial primary completion date • Breast Cancer • Cervical Cancer • Cholangiocarcinoma • Colorectal Cancer • Endocrine Cancer • Gastric Cancer • Gynecologic Cancers • Head and Neck Cancer • Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer • Prostate Cancer • Renal Cell Carcinoma • Solid Tumor • Thyroid Gland Carcinoma • Vulvar Cancer